| Atorvastatin attenuates oxidative stress in Alzheimer＇s disease |
| |
| 作者姓名： | Cai Zhiyou Yan Yong Wang Yonglong |
| |
| 作者单位： | Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chong qing 400016,China |
| |
| 基金项目： | Supported by the Doctoral Project of Chongqing Medical University （2006010068）. |
| |
| 摘 要： | Objective： To investigate serum level of SOD, MDA, ox-LDL, AchE and Ach in AD, to study atorvastatin influence on serum level of SOD, MDA, ox-LDL, Ache and Ach in AD and its neuroprotection mechanisms. Methods Subjects were divided into： normal blood lipid level group with Alzheimer＇s disease （A）, higher blood lipid level group with Alzheimer＇s disease （AH）, normal blood lipid level Alzheimer＇s disease group with atorvastatin treeatment （AT）, higher blood lipid level Alzheimer＇s disease group with atorvastatin treeatment（AHT）. Ox-LDL was measured by enzyme linked immunosorbent assay; SOD, MDA, ox-LDL, AchE, Ach and blood lipid level in AD was measured by biochemistry. Results： The serum level of MDA, Ache in AH group after atorvastatin treatment is lower ;The serum level of SOD, Ach in AH group is more increased than that of in A group; The serum level of ox-LDL in AH, A groups is lower than that of in A group; The dementia degree is lower after atorvastatin treatment. Conclusion： Atorvastatin can decrease serum level of MDA, AchE and ox-LDL, and increase that of SOD, Ach, and attenuate dementia symptom in AD, especially, with hyperlipemia. The hypothesis of atorvastatin neuroprotection is concluded that atorvastatin may restrain free radical reaction and retard oxidation in AD.
|
| 关 键 词： | 过氧化歧化酶 低密度脂蛋白 老年性痴呆 神经因素 |
| 收稿时间： | 2007-07-25 |
| 修稿时间： | 2007-11-29 |
Atorvastatin attenuates oxidative stress in Alzheimer's disease |
| |
| Cai Zhiyou Yan Yong Wang Yonglong.Atorvastatin attenuates oxidative stress in Alzheimer''''s disease[J].Journal of Medical Colleges of PLA(China),2008,23(1):31-37. |
| |
| Authors: | Cai Zhiyou Yan Yong Wang Yonglong |
| |
| Institution: | Department of Neurology, the First Affiliated Hospital of Chongqing Medical University, Chong qing 400016,China |
| |
| Abstract: | Objective: To investigate serum level of SOD, MDA, ox-LDL, AchE and Ach in AD, to study atorvastatin influence on serum level of SOD, MDA, ox-LDL, AchE and Acb in AD and its neuroprotection mechanisms. Methods Subjects were divided into: normal blood lipid level group with Alzheimer's disease (A), higher blood lipid level group with Alzheimer's disease (AH), normal blood lipid level Alzheimer's disease group with atorvastatin treeatment (AT),higher blood lipid level Alzheimer's disease group with atorvastatin treeatment(AHT). Ox-LDL was measured by enzyme linked immunosorbent assay; SOD, MDA, ox-LDL, AchE, Ach and blood lipid level in AD was measured by biochemistry. Results: The serum level of MDA, AchE in AH group after atorvastatin treatment is lower ;The serum level of SOD, Ach in AH group is more increased than that of in A group; The serum level of ox-LDL in AH, A groups is lower than that of in A group; The dementia degree is lower after atorvastatin treatment. Conclusion: Atorvastatin can decrease serum level of MDA, AchE and ox-LDL, and increase that of SOD, Acb, and attenuate dementia symptom in AD, especially, with hyperlipemia. The hypothesis of atorvastatin neuroprotection is concluded that atorvastatin may restrain free radical reaction and retard oxidation in AD. |
| |
| Keywords: | Atorvastatin Alzheimer's disease Superoxide dismutase Matondialdehyde Oxidized low-density lipoprotein |
| 本文献已被 维普 万方数据 ScienceDirect 等数据库收录！ |
|
